A Single-Cell Atlas of the Breast Cancer Microenvironment Identifies Subtype-Specific Tumor-Immune Landscapes and Vulnerabilities
Zisman Schachter, L. P.; pinhasi, A.; Yizhak, K.
Show abstract
Breast cancer is a heterogeneous disease, with prognosis and treatment shaped by subtype and stage. In this study we integrated 31 single-cell RNA-seq datasets, totaling 1.2 million cells from 376 samples. Our analysis revealed distinct subtype- and stage-specific TME states, and in both TNBC and Luminal A, we uncovered connections between tumor-intrinsic programs and the microenvironment, directly linked to patient survival and therapeutic response. In TNBC, tumor programs differed by stage, with primaries linked to immune-modulatory states and metastases to poor survival. These programs showed elevated TROP2 expression, suggesting sensitivity to TROP2-targeted therapies. Stage-specific checkpoints linked tumor programs to PD-1/LAG3 in primaries and CTLA-4 in metastases. In Luminal A, ER tumors showed proliferative signaling linked to favorable endocrine therapy response but also immune exclusion, whereas ER- tumors exhibited MYC-driven programs with poor prognosis, yet higher immune infiltration. Our breast cancer atlas outlines evolving therapeutic vulnerabilities, providing a framework for precision medicine and clinical trials design.
Matching journals
The top 8 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Multiplexed RNA-FISH-guided Laser Capture Microdissection RNA Sequencing Improves Breast Cancer Molecular Subtyping, Prognostic Classification, and Predicts Response to Antibody Drug Conjugates 98%
- Time-, tissue- and treatment-associated heterogeneity in tumour-residing migratory DCs 96%
- A recurrent pathogenic BRCA2 truncating variant reveals a role for BRCA2-PCAF complex in modulating NF-κB-driven transcription 96%
Similar papers in this journal
- Genome-wide identification and analysis of prognostic features in human cancers 97%
- Evolution of chromosome arm aberrations in breast cancer through genetic network rewiring 97%
- Distinct mutational processes shape selection of MHC class I and class II mutations across primary and metastatic tumors 96%
Similar papers in this journal
- Cancer-associated fibroblast compositions change with breast cancer progression linking S100A4 and PDPN ratios with clinical outcome 98%
- Differential chromatin accessibility and transcriptional dynamics define breast cancer subtypes and their lineages 97%
- Cell cycle alterations associate with a redistribution of mutation rates across chromosomal domains in human cancers 95%
Similar papers in this journal
- Acquired mutations and transcriptional remodeling in long-term estrogen-deprived locoregional breast cancer recurrences 96%
- Integrative multi-omic sequencing reveals the MMTV-Myc mouse model mimics human breast cancer heterogeneity 96%
- Mutational landscape of pure ductal carcinoma in situ and associations with disease prognosis and response to radiotherapy 96%
Similar papers in this journal
- Cell states and neighborhoods in distinct clinical stages of primary and metastatic esophageal adenocarcinoma 97%
- Combined tumor and immune signals from genomes or transcriptomes predict outcomes of checkpoint inhibition in melanoma 96%
- Systematic annotation of orphan RNAs reveals blood-accessible molecular barcodes of cancer identity and cancer-emergent oncogenic drivers 96%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.